Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kohlmann

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Archives of Microbiology|May 3, 1976
The coupling effects of some thiol and other sulfur-containing compounds on the circadian rhythm of cell division in photosynthetic mutants of EuglenaL N Edmunds, M E Jay, A Kohlmann, et al.
Leukemia|February 19, 2010
AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletionsC Haferlach, F Dicker, A Kohlmann, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 8, 2006
New insights into the biology of acute myeloid leukemia and their impact on treatmentW Hiddemann, T Haferlach, C Schoch, et al.
Leukemia|February 23, 2011
Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevanceV Grossmann, A Kohlmann, C Eder, et al.
Blood Cancer Journal|September 4, 2012
Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myelomaV Grossmann, U Bacher, V Artusi, et al.
Leukemia|July 21, 2012
GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosisA Fasan, C Eder, C Haferlach, et al.
Leukemia|April 16, 2011
Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristicsU Bacher, W Kern, T Alpermann, et al.
Leukemia|March 29, 2013
High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemiaV Grossmann, S Schnittger, F Poetzinger, et al.
Leukemia|July 30, 2015
Next-generation deep-sequencing detects multiple clones of CALR mutations in patients with BCR-ABL1 negative MPNS Jeromin, A Kohlmann, M Meggendorfer, et al.
Leukemia|January 22, 2011
Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedureV Grossmann, A Kohlmann, H-U Klein, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Archives of Microbiology|May 3, 1976
The coupling effects of some thiol and other sulfur-containing compounds on the circadian rhythm of cell division in photosynthetic mutants of EuglenaL N Edmunds, M E Jay, A Kohlmann, et al.
Leukemia|February 19, 2010
AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletionsC Haferlach, F Dicker, A Kohlmann, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 8, 2006
New insights into the biology of acute myeloid leukemia and their impact on treatmentW Hiddemann, T Haferlach, C Schoch, et al.
Leukemia|February 23, 2011
Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevanceV Grossmann, A Kohlmann, C Eder, et al.
Blood Cancer Journal|September 4, 2012
Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myelomaV Grossmann, U Bacher, V Artusi, et al.
Leukemia|July 21, 2012
GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosisA Fasan, C Eder, C Haferlach, et al.
Leukemia|April 16, 2011
Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristicsU Bacher, W Kern, T Alpermann, et al.
Leukemia|March 29, 2013
High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemiaV Grossmann, S Schnittger, F Poetzinger, et al.
Leukemia|July 30, 2015
Next-generation deep-sequencing detects multiple clones of CALR mutations in patients with BCR-ABL1 negative MPNS Jeromin, A Kohlmann, M Meggendorfer, et al.
Leukemia|January 22, 2011
Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedureV Grossmann, A Kohlmann, H-U Klein, et al.
Pageof 5